These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Botulinum toxin type A improves blood flow in vascular thoracic outlet syndrome. Danielson K; Odderson IR Am J Phys Med Rehabil; 2008 Nov; 87(11):956-9. PubMed ID: 18936559 [TBL] [Abstract][Full Text] [Related]
5. Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases. Işeri M; Işeri PK Kulak Burun Bogaz Ihtis Derg; 2004; 12(3-4):99-102. PubMed ID: 16010109 [TBL] [Abstract][Full Text] [Related]
6. Commercial preparations and handling of botulinum toxin type A and type B. Parish JL Clin Dermatol; 2003; 21(6):481-4. PubMed ID: 14759580 [TBL] [Abstract][Full Text] [Related]
7. [A new possibility for focal treatment of spasticity with botulinum neurotoxin. The Danish Society of Neurology]. Jeppesen LL; Dalager T; Meden P Ugeskr Laeger; 2004 Mar; 166(12):1117. PubMed ID: 15067776 [No Abstract] [Full Text] [Related]
8. Commentary: botulinum toxin in clinical medicine. Benedetto AV Clin Dermatol; 2003; 21(6):465-8. PubMed ID: 14759576 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin for the treatment of headaches: a review of current practices and evidence based-data. Ateş Y Agri; 2006 Jul; 18(3):5-11. PubMed ID: 17089224 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin for rejuvenation of the neck. Brandt FS; Boker A Clin Dermatol; 2003; 21(6):513-20. PubMed ID: 14759585 [TBL] [Abstract][Full Text] [Related]
12. A review of thoracic outlet syndrome and the possible role of botulinum toxin in the treatment of this syndrome. Foley JM; Finlayson H; Travlos A Toxins (Basel); 2012 Nov; 4(11):1223-35. PubMed ID: 23202313 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction. Rajkumar GN; Conn IG Urology; 2004 Jul; 64(1):2-8. PubMed ID: 15245922 [No Abstract] [Full Text] [Related]
14. Single CT-guided chemodenervation of the anterior scalene muscle with botulinum toxin for neurogenic thoracic outlet syndrome. Christo PJ; Christo DK; Carinci AJ; Freischlag JA Pain Med; 2010 Apr; 11(4):504-11. PubMed ID: 20202146 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin in the lower one third of the face. Atamoros FP Clin Dermatol; 2003; 21(6):505-12. PubMed ID: 14759584 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Spasticity after Botulinum Toxin Injection Using Paired-Pulse Transcranial Magnetic Stimulation. Chia CH; Li F; Li QY; Qin WT Chin Med J (Engl); 2018 Nov; 131(22):2763-2764. PubMed ID: 30425208 [No Abstract] [Full Text] [Related]
17. Patient management and treatment technique. Sattler G Clin Dermatol; 2003; 21(6):485-7. PubMed ID: 14759581 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin treatment for upper lid retraction of dysthyroidism. Chuenkongkaew W J Med Assoc Thai; 2003 Nov; 86(11):1051-4. PubMed ID: 14696787 [TBL] [Abstract][Full Text] [Related]